NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS

The present invention discloses compounds according to Formula I: Wherein R13, R1\ R2, R4, R5, R63, R6 7 8 W, X, Cy, and the subscript a are as defined herein. The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions c...

Full description

Saved in:
Bibliographic Details
Main Authors HECKMANN, BERTRAND, BRYS, REGINALD CHRISTOPHE XAVIER, DESROY, NICOLAS, PEIXOTO, CHRISTOPHE, JONCOUR, AGNES, BOCK, XAVIER
Format Patent
LanguageEnglish
Published 13.07.2019
Online AccessGet full text

Cover

Loading…
Abstract The present invention discloses compounds according to Formula I: Wherein R13, R1\ R2, R4, R5, R63, R6 7 8 W, X, Cy, and the subscript a are as defined herein. The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving fibrotic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, and/or abnormal angiogenesis associated diseases by administering the compound of the invention.
AbstractList The present invention discloses compounds according to Formula I: Wherein R13, R1\ R2, R4, R5, R63, R6 7 8 W, X, Cy, and the subscript a are as defined herein. The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving fibrotic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, and/or abnormal angiogenesis associated diseases by administering the compound of the invention.
Author PEIXOTO, CHRISTOPHE
BRYS, REGINALD CHRISTOPHE XAVIER
BOCK, XAVIER
DESROY, NICOLAS
JONCOUR, AGNES
HECKMANN, BERTRAND
Author_xml – fullname: HECKMANN, BERTRAND
– fullname: BRYS, REGINALD CHRISTOPHE XAVIER
– fullname: DESROY, NICOLAS
– fullname: PEIXOTO, CHRISTOPHE
– fullname: JONCOUR, AGNES
– fullname: BOCK, XAVIER
BookMark eNqFissKwjAQRbvQha9fkPkBoSroekgmNNBkSjIVuiqlxJW0hfr_qNC9q3s4526z1TAOaZP1nh9UgmJXce11BPQaqgKDQ0W1WIVLjFYs-whSUCA2YDj8GCQQiiMv8JXWmxKdQ-HQgLaRg6YQ99n62b3mdFh2lx0NiSpOaRrbNE9dn4b0bl1zvueXW47Xv4cPdtQ1ZQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID MY170260A
GroupedDBID EVB
ID FETCH-epo_espacenet_MY170260A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:47:52 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_MY170260A3
Notes Application Number: MY2015PI703027
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190713&DB=EPODOC&CC=MY&NR=170260A
ParticipantIDs epo_espacenet_MY170260A
PublicationCentury 2000
PublicationDate 20190713
PublicationDateYYYYMMDD 2019-07-13
PublicationDate_xml – month: 07
  year: 2019
  text: 20190713
  day: 13
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies GALAPAGOS NV
RelatedCompanies_xml – name: GALAPAGOS NV
Score 3.2121515
Snippet The present invention discloses compounds according to Formula I: Wherein R13, R1\ R2, R4, R5, R63, R6 7 8 W, X, Cy, and the subscript a are as defined herein....
SourceID epo
SourceType Open Access Repository
Title NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190713&DB=EPODOC&locale=&CC=MY&NR=170260A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT4MwEL_MadQ3nd8fSx8Mb8RNPiYPxDAoYWYFAt2yPS3AwPjCFofx3_eKTH3ZW9Mm1_aS693v2vsV4CFHZGIUui7jyWfIqp4asqEVuoyhh1Jk_UEvKURCn_m6N1FfZ9qsBW_bWpiaJ_SrJkdEi8rQ3qv6vF7_JbGc-m3l5jF9x67Vi8tNR2rQMXo3BF2SMzRpGDiBLdm2yeaSH5k4K0bu1h7sYww9EKZAp0NRkrL-70_cEzgIUVRZnUIrLztwZG-_XevAIWtuu7HZGN7mDDI_mNIxsQMWBhPfiYnlOyT0rIhZNp1wQWrwMxiP6rpgwj0a0cAlCPJEm_CIWlwQ9xPsHPnu2GLM4kE0J84oRiBIo_gcui7ltifjahe_elmwebMr5QLa5arMr4DkghPqWenlSaqqmvKUKMlSENZo2hKDt1S_hssdQm52jtzCsVCtyGj2lTtoVx-f-T264irt1mr8Bh4AhiU
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT4NAEJ7Uaqw3re9H3YPhRmzlUTkQQ2EJKAsEaNOeGmjBeMHGYvz7ziJVL71tdpPZ3UlmZ77ZnW8B7nJEJlqhqiKefJooq5kmakqhihh6SMViMOynBU_oM191xvLzVJm24HVTC1PzhH7V5IhoUQu096o-r1d_SSyrflu5vs_esOv9yU50S2jQMXo3BF2CNdJpGFiBKZimzmaCH-k4K0buxg7sYnw95KZAJyNekrL670_sQ9gLUVRZHUErL7vQMTffrnVhnzW33dhsDG99DAs_mFCPmAELg7FvxcTwLRI6RsQMk44TTmrwMxi7dV0wSRwa0cAmCPJ4myQRNRJO3E-w0_Vtz2DMSIJoRiw3RiBIo_gEejZNTEfE1c5_9TJns2ZX0im0y_cyPweSc06oR6mfp5ksK9JDKqVLTlijKEsM3jL1As62CLncOnILHSdh3txz_ZcrOOBq5tnNgXQN7erjM79Bt1xlvVql35TPiRg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NOVEL+COMPOUNDS+AND+PHARMACEUTICAL+COMPOSITIONS+THEREOF+FOR+THE+TREATMENT+OF+INFLAMMATORY+DISORDERS&rft.inventor=HECKMANN%2C+BERTRAND&rft.inventor=BRYS%2C+REGINALD+CHRISTOPHE+XAVIER&rft.inventor=DESROY%2C+NICOLAS&rft.inventor=PEIXOTO%2C+CHRISTOPHE&rft.inventor=JONCOUR%2C+AGNES&rft.inventor=BOCK%2C+XAVIER&rft.date=2019-07-13&rft.externalDBID=A&rft.externalDocID=MY170260A